NeuroPace (NPCE) to Release Quarterly Earnings on Tuesday

NeuroPace (NASDAQ:NPCE) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, August 13th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

NeuroPace Trading Down 2.2 %

Shares of NeuroPace stock opened at $6.98 on Monday. NeuroPace has a 52-week low of $4.21 and a 52-week high of $18.15. The firm has a market capitalization of $200.80 million, a PE ratio of -5.87 and a beta of 1.80. The company has a debt-to-equity ratio of 4.05, a current ratio of 6.43 and a quick ratio of 5.56. The company’s fifty day moving average price is $7.11 and its two-hundred day moving average price is $11.07.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Cantor Fitzgerald reissued an “overweight” rating and issued a $18.00 target price on shares of NeuroPace in a research note on Thursday, May 9th. Morgan Stanley lowered their price objective on NeuroPace from $9.50 to $8.00 and set an “equal weight” rating on the stock in a research note on Monday, July 15th. One analyst has rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $14.83.

NeuroPace Company Profile

NeuroPace, Inc operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely.